Australia secures 10m additional COVID vaccine doses Pfizer/BioNTech have agreed to double the number of doses they will be sending to Australia. Where does that leave us?
Novavax confirms efficacy against emerging coronavirus variants New data on Australia’s third vaccine candidate shows it is highly effective against most COVID-19 variants, which may prove crucial as production bottlenecks force delays among other options.
Will the new COVID vaccine ads help curb hesitancy? The $24 million campaign is aimed at reassuring Australians that the vaccines used in the rollout are safe and effective.
COVID vaccines not yet recommended for pregnant women RANZCOG made the recommendation after reviewing all available evidence.
Don’t panic: New COVID strains are not ‘escape mutants’ and vaccines should still work The variants have shut down nations and led to surges of new cases and deaths – but experts say current vaccines should still protect against the mutations.
Federal Government confirms new COVID vaccine item numbers General practices stand to receive between $65 and $74.90 for each fully vaccinated patient.
Government seeks general practice EOIs for COVID vaccine rollout GPs will form the backbone of ‘one of the greatest logistical exercises’ in Australian history.
At least 500 private healthcare staff to assist with COVID vaccines They will augment the role performed by general practice, which the Federal Health Minister described as the ‘cornerstone’ of the rollout.
It’s crucial COVID vaccine hesitancy among health workers is addressed Deputy Chair for the Collaboration on Social Science and Immunisation Associate Professor Holly Seale reveals where to start.
Novavax candidate may prove best long-term solution for Australia While debate swirls around the first two vaccines set to be used in the rollout, NVX-CoV2373 comes with potential advantages.